Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. A. O'Connor
The Combination of the Proteasome Inhibitor Bortezomib and the BCL-2 Antisense Molecule Oblimersen Sensitizes Human B-Cell Lymphomas to Cyclophosphamide
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics
Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
PLoS ONE
Multidisciplinary
Effects of the Proteasome Inhibitor Bortezomib in Combination With Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-Analysis
Turkish Journal of Haematology
Hematology
Proteasome Inhibitor Bortezomib Modulates TLR4-induced Dendritic Cell Activation
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)
Blood Cancer Journal
Oncology
Hematology
EZH2 Inhibition Re-Sensitizes Multidrug Resistant B-Cell Lymphomas to Etoposide Mediated Apoptosis
Oncoscience
Cancer Research
Oncology
From Bortezomib to Other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Calcineurin and M-Tor Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-Ii Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The Proteasome Inhibitor Bortezomib Attenuates Renal Fibrosis in Mice via the Suppression of TGF-β1
Scientific Reports
Multidisciplinary
